AMD112
RNA delivery for gene editing
PreclinicalActive
Key Facts
About Holy Stone Healthcare
Taiwan biotech leveraging hyaluronic‑acid biopolymers for targeted brain, eye, and tumor drug delivery.
View full company profileRNA delivery for gene editing
Taiwan biotech leveraging hyaluronic‑acid biopolymers for targeted brain, eye, and tumor drug delivery.
View full company profile